Santen Pharmaceutical Co., Ltd. held its 110th Annual General Meeting of Shareholders for the the fiscal year 2021 on June 24, 2022. The Meeting started at 10:00 a.m. and ended 10:54 a.m. The number of shareholders attended was 38.
- Reports on the Business Report, Consolidated Financial Statements and Financial Statements for the 110th Business Term (April 1, 2021 to March 31, 2022)
- Reports on the Audit Reports by the Accounting Auditors and the Board of Corporate Auditors on the Consolidated Financial Statements for the 110th Business Term (April 1, 2021 to March 31, 2022)
We received questions regarding the following subjects from shareholders in advance and answered each question.
- Situation of current stock price
- Status of product development
- Appointment of outside directors
- Abolition of hand gifts to attended shareholders
There was no question submitted by shareholders present at the meeting.
|Matters resolved||Six proposals were all resolved.|
Please refer to the Resolution Notice (PDF: 111KB)PDF file.Page will open in a new window. for detailed resolutions.